129 related articles for article (PubMed ID: 38345056)
1. Association of Systemic Markers of Inflammation with Signs and Symptoms of Dry Eye Disease and Sjogren's Syndrome in the Dry Eye Assessment and Management (DREAM©) Study.
Hashemi MH; Ambrus JL; Shukla AA; Zhu D; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jun; 49(6):574-581. PubMed ID: 38345056
[TBL] [Abstract][Full Text] [Related]
2. Utility of Novel Autoantibodies in the Diagnosis of Sjögren's Syndrome Among Patients With Dry Eye.
Karakus S; Baer AN; Agrawal D; Gurakar M; Massof RW; Akpek EK
Cornea; 2018 Apr; 37(4):405-411. PubMed ID: 29504954
[TBL] [Abstract][Full Text] [Related]
3. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
[TBL] [Abstract][Full Text] [Related]
5. Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.
Everett S; Vishwanath S; Cavero V; Shen L; Suresh L; Malyavantham K; Lincoff-Cohen N; Ambrus JL
BMC Ophthalmol; 2017 Mar; 17(1):20. PubMed ID: 28270126
[TBL] [Abstract][Full Text] [Related]
6. Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study.
Kuklinski EJ; Yu Y; Ying GS; Asbell PA;
Invest Ophthalmol Vis Sci; 2023 Sep; 64(12):7. PubMed ID: 37669063
[TBL] [Abstract][Full Text] [Related]
7. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
8. Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.
Garcia DM; Reis de Oliveira F; Módulo CM; Faustino J; Barbosa AP; Alves M; Rocha EM
PLoS One; 2018; 13(12):e0208420. PubMed ID: 30507949
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
[TBL] [Abstract][Full Text] [Related]
10. Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.
Sloesen B; Young A; Forde K; Hodson N; Bentley S; Walsh O; Naujoks C; O'Brien P; Sharma G
J Patient Rep Outcomes; 2023 Jul; 7(1):64. PubMed ID: 37405617
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies.
Armağan B; Robinson SA; Bazoberry A; Perin J; Grader-Beck T; Akpek EK; Kim J; Baer AN
Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1559-1565. PubMed ID: 33742788
[TBL] [Abstract][Full Text] [Related]
12. Isolated anti-Ro52 identifies a severe subset of Sjögren's syndrome patients.
Lee AYS; Putty T; Lin MW; Swaminathan S; Suan D; Chataway T; Thurlings RM; Gordon TP; Wang JJ; Reed JH
Front Immunol; 2023; 14():1115548. PubMed ID: 37006271
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations in anti-Ro52/SS-A antibody-seropositive patients with Sjögren's syndrome.
Nakamura H; Morimoto S; Shimizu T; Takatani A; Nishihata SY; Kawakami A
Immunol Med; 2021 Dec; 44(4):252-262. PubMed ID: 33989125
[No Abstract] [Full Text] [Related]
14. Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA.
Mekinian A; Nicaise-Roland P; Chollet-Martin S; Fain O; Crestani B
Rheumatology (Oxford); 2013 Dec; 52(12):2223-8. PubMed ID: 24026249
[TBL] [Abstract][Full Text] [Related]
15. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
17. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
Suresh L; Malyavantham K; Shen L; Ambrus JL
BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
[TBL] [Abstract][Full Text] [Related]
18. Different perception of dry eye symptoms between patients with and without primary Sjogren's syndrome.
Kim M; Chun YS; Kim KW
Sci Rep; 2022 Feb; 12(1):2172. PubMed ID: 35140286
[TBL] [Abstract][Full Text] [Related]
19. Anti-La positive, anti-Ro negative subset of primary Sjögren's syndrome: anti-La is a reality but is the disease?
Danda D; Sharma R; Truong D; Koelsch KA; Kurien BT; Bagavant H; Deshmukh U; Kaufman CE; Lewis DM; Stone DU; Radfar L; Rasmussen A; Sivils KL; Scofield RH
Clin Exp Rheumatol; 2017; 35(3):438-444. PubMed ID: 28229827
[TBL] [Abstract][Full Text] [Related]
20. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
